IDH1 and glioblastoma: Some studies have found that even in patients with IDH wild-type LrGG, tumors exhibit high levels of aggressiveness, with overall survival times similar to those of IDH wild-type GBM (Eckel-Passow et al., 2015; Wijnenga et al., 2017).